FDA Inspection 1261583 - Summit Biosciences Inc. - February 21, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Summit Biosciences Inc., with an inspection on February 21, 2025, issued by the Cincinnati District Office, covering human drugs.

Company: Summit Biosciences Inc.
Inspection Date: February 21, 2025
Product Type: Human Drugs
Office: Cincinnati District Office

Open in Dashboard

ID · fbf78c84-7d7e-4694-9f67-ee101159342d

Violation Codes2

21 CFR 211.110(a)FDCA 582(b)(4)

Full citation text and observation details available on the Dashboard.